43 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
the product;
we, or any of our collaborators, may be required to recall the product, change the way the product is administered or conduct additional clinical … licensees submit;
voluntary or mandatory recall;
fines;
refusal to permit the import or export of our products;
product seizure or detentions
6-K
EX-99
BLRX
Bioline Rx Ltd
30 Aug 23
Current report (foreign)
6:45am
Product may be subject to any recall, corrective action or other regulatory action taken by virtue of Applicable Laws (a “Remedial Action”). BioLine
6-K
EX-10.1
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal
6-K
EX-10.1
lshzplmlwxo
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
wtldgr ff6i
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-10.1
9eo076x4dvjklvzw011l
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-99
bgkdzov x23b7
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
89fz1su 5rug
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
wegoap m8x
7 Feb 19
As Representative of the several Underwriters
12:00pm
20-F/A
EX-4.40
qtvl 8qiol
31 May 16
Annual report (foreign) (amended)
12:00am